Polygalacin D2

Polygalacin D2
Product Name Polygalacin D2
CAS No.: 66663-92-1
Catalog No.: CFN95241
Molecular Formula: C63H102O32
Molecular Weight: 1371.5 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: Powder
Targets: Antifection
Source: The roots of Polygala tenuifolia Willd
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $413/5mg
Polygalacin D2 may have antimicrobial activity.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Fitoterapia.2024, 175:105955.
  • Molecules.2023, 28(10):4062.
  • Evid Based Complement Alternat Med.2017, 2017:1583185
  • Biol Pharm Bull.2018, 41(11):1685-1693
  • Biomolecules.2022, 12(12):1754.
  • BMC Complement Med Ther. 2020, 20(1):91.
  • Antioxidants (Basel).2021, 10(8):1300.
  • J Holistic Integrative Pharm.2023, 4(1):14-28
  • Int J Immunopathol Pharmacol.2019, 33:2058738419857537
  • Chem Biodivers.2023, 20(12):e202301461.
  • Arganine E

    Catalog No: CFN91580
    CAS No: 144442-86-4
    Price: $318/5mg
    Cauloside F

    Catalog No: CFN93269
    CAS No: 60451-47-0
    Price: Inquiry(manager@chemfaces.com)
    Hederacoside C

    Catalog No: CFN90183
    CAS No: 14216-03-6
    Price: $40/20mg
    Dipsacoside B

    Catalog No: CFN99150
    CAS No: 33289-85-9
    Price: $50/20mg
    Akebia saponin E

    Catalog No: CFN95619
    CAS No: 39524-14-6
    Price: $318/20mg
    Pulsatilla saponin H

    Catalog No: CFN80187
    CAS No: 68027-14-5
    Price: Inquiry(manager@chemfaces.com)
    Tubeimoside I

    Catalog No: CFN99990
    CAS No: 102040-03-9
    Price: $40/20mg
    Secotubeimoside I

    Catalog No: CFN95347
    CAS No: 106235-32-9
    Price: $318/10mg
    Tubeimoside II

    Catalog No: CFN90915
    CAS No: 115810-12-3
    Price: $40/20mg
    Tubeimoside III

    Catalog No: CFN90916
    CAS No: 115810-13-4
    Price: $168/20mg
    Planta Medica, 2005, 71(6):566-568.
    Isolation of a new saponin and cytotoxic effect of saponins from the root of Platycodon grandiflorum on human tumor cell lines.[Reference: WebLink]

    METHODS AND RESULTS:
    A novel triterpenoid saponin, deapioplatycoside E (1) was isolated from the root extract of Platycodon grandiflorum, together with the seven known saponins 2 - 8, i. e., platycoside E (2), deapioplatycodin D3 (3), platycodin D3 (4), Polygalacin D2 (5), platycodin D2 (6), deapioplatycodin D (7) and platycodin D (8). The structure of the new saponin 1 was determined on the basis of spectral analysis and chemical evidence.
    CONCLUSIONS:
    The crude saponin fraction (ED50: ca. 10 - 15 microg/mL) and compounds 6 - 8 (ED50: ca. 4 - 18 microg/mL) exhibited significant inhibition on the proliferation of five kinds of cultured human tumor cell lines, i. e., A549 (non-small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nerve system) and HCT-15 (colon), in vitro.
    Journal of the korean society of food science & nutrition, 2016, 45(7):1017-1025.
    Changes in Platycoside Components and Antimicrobial Activities of Bronchus Disease-Inducing Bacteria of Fermented Platycodon grandiflorum Root by Lactic Acid Bacteria.[Reference: WebLink]
    This study was performed in order to investigate changes in platycosides, as well as antimicrobial activities of bronchus diseases-inducing bacteria (Corynebacterium diphtheriae, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes) of Platycodon grandiflorum root (PGR) fermented by lactic acid bacteria (Leuconostoc mesenteroides N12-4, Leuc. mesenteroides N58-5, Lactobacillus plantarum N76-10, L. plantarum N56-12, Lactobacillus brevis N70-9, and L. brevis E3-8).
    METHODS AND RESULTS:
    Growth of L. plantarum on PGR was most active during lactic acid fermentation using different strains. Total platycoside, platycoside E, platycodin A, Polygalacin D2, polygalacin D, and diapioplatycoside E contents of PGR fermented for 96 h at 37°C by Leuc. mesenteroides and L. plantarum increased, whereas contents of platycodin D and platycodin D3 were reduced. The antimicrobial activity on PGR fermented by L. plantarum N56-12 exhibited strong microbial proliferation for all four kinds of bronchus disease-inducing bacteria and was higher than that of non-fermented PGR extract. MIC of fermented PGR extract by L. plantarum N56-12 on C. diphtheriae, K. pneumoniae, S. aureus, and S. pyogenes were 45, 10, 50, and 25 mg/mL, respectively.
    CONCLUSIONS:
    Thus, this result shows that the antimicrobial activities of bronchus disease-inducing bacteria and platycoside content of PGR by L. plantarum N56-12 were higher than that of non-fermented PGR extract.
    Asian Journal of Chemistry, 2013,25(13):7093-7097.
    Quantitative Determination of Triterpenoidal Saponins in Platycodi radix and Its Variation in Different Regions of Korean Peninsula: A Herbal Plant Used as Traditional Medicine.[Reference: WebLink]
    This survey was undertaken in different provinces in order to evaluate the contents of triterpenoidal saponins in Platycodi radix and its variation in different regions of Korea.
    METHODS AND RESULTS:
    HPLC and ESI-MS analysis were conducted for identification and quantification of ten know and four unknown compounds. Fourteen saponin compounds such as deapio-platycoside E, platycoside E, platycodin D3, platyconic acid A, platycodin D2, platycodin D, mixture of Polygalacin D2 and 3'-O-acetyl-platycodin D, polygalacin D, 3'-O-acetyl- polygalacin D, 2'-Oacetyl- platycodin D and four unknown compounds widely ranged from 2,643 to 23,599 mg/kg dry weight (DW) in the 3-year-old roots and from 5,693 to 34,205 mg/kg DW in the 2-year-old roots, respectively.
    CONCLUSIONS:
    Since KFDA has not assigned any individual compounds for the quality control of Platycodi radix, we would suggest using Platycodi radix from the region of Jinan because the samples contain moderate total saponins contents.
    cis-Mulberroside A

    Catalog No: CFN95006
    CAS No: 166734-06-1
    Price: $368/10mg
    Mirificin-4'-O-glucoside

    Catalog No: CFN95091
    CAS No: 168035-01-6
    Price: $288/5mg
    Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside

    Catalog No: CFN95109
    CAS No: 868557-54-4
    Price: $338/5mg
    Astin A

    Catalog No: CFN95187
    CAS No: 151201-75-1
    Price: $318/10mg
    Bruceantinol B

    Catalog No: CFN95216
    CAS No: 1822332-33-1
    Price: $318/5mg
    Planispine A

    Catalog No: CFN95348
    CAS No: 1202761-42-9
    Price: $318/10mg
    Apigenin 6,8-di-C-alpha-L-arabinopyranoside

    Catalog No: CFN95360
    CAS No: 73140-47-3
    Price: $318/10mg
    New compound 15

    Catalog No: CFN95413
    CAS No: N/A
    Price: $413/5mg
    5-Hydroxy-4a,8-dimethyl-3-methylen-decahydroazuleno[6,5-b]furan-2(3H)-on

    Catalog No: CFN95522
    CAS No: 114579-31-6
    Price: $318/5mg
    Dihydroconfertin

    Catalog No: CFN95523
    CAS No: 68832-40-6
    Price: $318/5mg